Compare Edwards Lifesciences Corporation Common Stock (EW) vs Li Auto Inc (LI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Li Auto Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Li Auto Inc trades at $11.31 (market cap $10.71B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4.5× Li Auto Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals.
| EW | LI | |
|---|---|---|
Market Cap | $48.56B | $10.71B |
Volume | 6,520,488 | 1,781,143 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $23.61 |
52-Week Low | $72.65 | $10.69 |
Enterprise Value | $45.01B | $139.58M |
Typical Hold Time | — | 101 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Li Auto (LI) trades at $10.99, down 0.92% on the day and near 52-week lows amid weak delivery numbers and earnings misses. The stock shows bearish technical signals with negative moving averages, though RSI indicates potential oversold conditions. Fundamentally, revenue declined to $112.31B in 2025 with net income margin turning negative at -4.4%, while valuation metrics show mixed signals with low P/S of 0.73 but high P/E of 99.38. Recent news highlights delivery moderation and new model launches as the company faces intense EV competition.
The outlook remains challenging with projected revenue decline to $104.8B and net loss of $4.6B in 2026. While analyst consensus suggests 38% upside to $15.18 price target, execution risks and cash burn pose significant headwinds. The stock's current discount to analyst targets presents opportunity, but requires careful monitoring of delivery recovery and margin improvement amid fierce Chinese EV competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →
